Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · IEX Real-Time Price · USD
7.15
+0.25 (3.62%)
Mar 27, 2024, 12:00 AM EDT - Market open

Pasithea Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202220212020
Net Income
-13.94-2.17-0.04
Depreciation & Amortization
0.1100
Share-Based Compensation
0.550.470
Other Operating Activities
-1.28-1.470
Operating Cash Flow
-14.56-3.17-0.04
Capital Expenditures
-2.14-0.020
Acquisitions
0.0800
Investing Cash Flow
-2.06-0.020
Share Issuance / Repurchase
-3.2157.240.28
Other Financing Activities
--1.31-
Financing Cash Flow
-3.2155.930.28
Exchange Rate Effect
0.01-0.010
Net Cash Flow
-19.8252.720.24
Free Cash Flow
-16.7-3.2-0.04
Free Cash Flow Margin
-3432.37%-21216.05%-
Free Cash Flow Per Share
-13.23-6.14-0.10
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).